A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Clinical trial NCT01474083 · COMPLETED

Trial details

NCT number: NCT01474083
Sponsor: vTv Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2011-11-01
Primary completion: 2012-08-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.